Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-21

Clinical Trial Update: Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery? [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports Phase 2 and Phase 3 studies evaluating Triesence (triamcinolone acetonide) used during glaucoma surgery to lower eye pressure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triesence (triamcinolone acetonide)

Snippet

Sponsor: Wills Eye | Conditions: Glaucoma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-03-21